When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TherapeuticsMD ( NASDAQ: TXMD ) appointed Brian Bernick and Mark Glickman as interim co-CEO and co-principal executive officers.
Bernick and Glickman succeed Hugh O’Dowd as CEO, the company said in a Sept. 12 press release.
Prior to this appointment, Bernick, the company's co-founder, served as chief scientific and medical officer, and Glickman served as chief business officer.
TherapeuticsMD also appointed Tommy Thompson, who served as chairman since 2012, as the executive chairman of the Board.